The Current Ratio as of December 2024 (TTM) for Athersys, Inc. (ATHX) is 0.06

According to Athersys, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.06. This represents a change of -67.55% compared to the average of 0.18 of the last 4 quarters.

Athersys, Inc. (ATHX) Historical Current Ratio (quarterly & annually)

How has ATHX Current Ratio performed in the past?

The mean historical Current Ratio of Athersys, Inc. over the last ten years is 3.49. The current 0.06 Current Ratio has changed 65.48% with respect to the historical average. Over the past ten years (40 quarters), ATHX's Current Ratio was at its highest in in the March 2014 quarter at 10.83. The Current Ratio was at its lowest in in the September 2023 quarter at 0.06.

Athersys, Inc. (ATHX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Athersys, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Athersys, Inc. (ATHX) Average Current Ratio

How has ATHX Current Ratio performed in the past?

The current Current Ratio of Athersys, Inc. (ATHX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Athersys, Inc. (ATHX) Current Ratio vs. Peers

How is ATHX’s Current Ratio compared to its peers?

Athersys, Inc.’s Current Ratio is less than LianBio (10.06), less than Eton Pharmaceuticals, Inc. (1.51), less than Galera Therapeutics, Inc. (9.74), less than Checkpoint Therapeutics, Inc. (0.29), less than YS Biopharma Co., Ltd. (0.94), less than Sonnet BioTherapeutics Holdings, Inc. (0.66), less than ZyVersa Therapeutics, Inc. (33.83), less than Allarity Therapeutics, Inc. (2.75), less than Kiromic BioPharma, Inc. (0.22), less than Avenue Therapeutics, Inc. (2.70), less than Hoth Therapeutics, Inc. (10.16), less than Revelation Biosciences, Inc. (1.64), less than NeuroBo Pharmaceuticals, Inc. (2.41), less than Virax Biolabs Group Limited (25.94), less than TransCode Therapeutics, Inc. (1.58), less than Fortress Biotech, Inc. (1.23), less than Akebia Therapeutics, Inc. (1.52), less than Trevena, Inc. (2.42), less than Reviva Pharmaceuticals Holdings, Inc. (0.39), less than Pyxis Oncology, Inc. (7.33), less than Zura Bio Limited (10.36), less than eFFECTOR Therapeutics, Inc. (1.03), less than Altamira Therapeutics Ltd. (1.38), less than Elevation Oncology, Inc. (17.77),

Build a custom stock screener for Athersys, Inc. (ATHX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Athersys, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Athersys, Inc. (ATHX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Athersys, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.